Global Home Infusion Therapy Market to Reach US$ 74.07 Billion by 2034 Amid Rising Demand for Home-Based Healthcare

Global Home Infusion Therapy Market Analysis

The global home infusion therapy market is projected to grow from US$ 45.28 billion in 2025 to US$ 74.07 billion by 2034, registering a compound annual growth rate (CAGR) of 5.62% during the forecast period. Market expansion is being driven by the increasing prevalence of chronic diseases, the growing global geriatric population, advancements in healthcare technologies, rising preference for home-based healthcare services, and the cost advantages associated with home infusion therapy.

Global Home Infusion Therapy Market Overview

Home infusion therapy is a healthcare treatment approach that involves administering medications, nutrients, and fluids directly into a patient’s body through intravenous or subcutaneous routes within the comfort of their home environment. The therapy is carried out under the supervision of healthcare professionals and supported by advanced medical technologies, enabling patients to receive hospital-quality treatment without requiring extended hospital stays. Home infusion therapy is commonly used for the treatment of various medical conditions, including severe infections requiring intravenous antibiotics, chronic illnesses such as diabetes and immune deficiency disorders, cancer treatments involving chemotherapy, dehydration management, pain management, and parenteral nutrition support. It is also widely utilized for conditions such as hemophilia, multiple sclerosis, and congestive heart failure.

Globally, home infusion therapy has gained substantial popularity due to the numerous benefits it offers to both patients and healthcare systems. Key advantages include reduced hospital admissions, lower risk of hospital-acquired infections, improved patient comfort, and enhanced recovery outcomes. In addition, ongoing advancements in medical technology, the rapidly growing elderly population, and the increasing incidence of chronic diseases have significantly contributed to the widespread adoption of home infusion therapy across healthcare markets worldwide.

Recent Developmental Activities in Infusion Pumps:

ICU Medical Inc. (NASDAQ: ICUI), a medical company, was granted the FDA 510(k) clearance for their single channel Plum Solo™ accurate intravenous (IV) pump in April 2025, which belongs to the Plum Duo™ series of infusion pumps.

Progressa+ Next Gen ICU bed was introduced by Baxter International Inc., an American health care company, in June 2023 for use in homecare patients who have critical needs at home. With the help of this product, nurses will be able to control therapies for their patients at home.

Premier Inc., an American healthcare company, made an agreement with Fresenius Kabi, a global healthcare company, in May 2023, leading to the generation of pricing and terms advantages for the Ivenix Infusion System.

Option Care Health, a leading healthcare services company, introduced an independent platform for homecare services in May 2023 with the help of Amedisys Inc., which is considered one of the most prominent companies in the home health services industry. The services offered by the company involve different medical professionals, like pharmacists, dietitians, therapists, social workers, among others, providing best-in-class healthcare services at home.

Medtronic introduces the world's first and only insulin pump infusion set that doubles the wear time to seven days in the United States in November 2022.

An independent company Shanghai MicroPort Lifesciences Co., Ltd. (MicroPort® Lifesciences), involved in the development of a novel AutoEx® Chemotherapy Infusion Pump (AutoEx®), received its marketing approval from the National Medical Products Administration (NMPA) of China in March 2022.

Request Sample Report:https://www.renub.com/request-sample-page.php?gturl=home-infusion-therapy-market-p.php

Trends in the Home Infusion Therapy Market

Advanced Infusion Pumps Equipped with Safety Software

There is a trend of using infusion pumps that are more safe and precise. For example, Baxter came up with its product, called Novum IQ Infusion Pump, connected to the Dose IQ safety software, aimed at improving dosage precision.

Infusion Devices Worn on the Body for Treatment

Infusion pumps are gaining popularity in treatment of various chronic diseases as wearable devices. In 2024, NHS presented the infusion device with foslevodopa-foscarbidopa, prescribed for people with Parkinson's disease, providing the drug round-the-clock.

Infusion Monitoring Systems With AI Technology

The use of AI technology in infusion pumps has become necessary in order to increase the safety. Thus, in 2024, there were launched infusion pumps equipped with AI technology that allowed assessing pressure patterns and predicting occlusion with an amazing accuracy.

Advanced Needle-Free Connectors & Infections Prevention

Infections prevention can be considered an additional trend in home infusions as well. For example, in 2024, such companies as B. Braun introduced their advanced needle-free connectors and intravenous (IV) lines, which helped to greatly reduce the chances of contracting a catheter-associated infection.

Connected & Multifunctional Infusion Equipment

Another area in which significant advancements have been made includes integration of infusion therapy into connected and multifunctional systems. From 2023 till 2025, various companies offered ambulatory pumps featuring wireless monitoring and telemedicine options that enabled medical professionals to manage multiple patients remotely.

Countries with the Highest Rate of Diabetes (2024)

Rank 1: Sweden

Rank 2: Denmark

 Rank 3: Iceland

Rank 4: Norway

Rank 5: Estonia

Rank 6: Bahamas

Rank 7: Netherlands

Rank 8: Hong Kong

Rank 9: Liechtenstein

Rank 10: Japan

Source: Renub Research

Growth Drivers of the Home Infusion Therapy Market

Rising Prevalence of Chronic Diseases and Long-Term Care Needs

The increasing prevalence of chronic diseases and the growing need for long-term medical care are among the primary factors driving the growth of the global home infusion therapy market. Conditions such as cancer, diabetes, immune disorders, gastrointestinal diseases, and severe infections often require extended treatment involving intravenous medications, nutritional support, and pain management therapies, making home infusion therapy a highly effective treatment option. According to the World Health Organization, approximately 10 million people worldwide died from cancer in 2021. In addition, the International Diabetes Federation reported that nearly 589 million adults were living with diabetes in 2021, with the number expected to rise to 853 million by 2050. The rapidly aging global population is also contributing to the increase in patients requiring prolonged medical care and chronic disease management. Home infusion therapy reduces the need for frequent hospital visits while ensuring continuous treatment for elderly and mobility-restricted patients who may face difficulties accessing healthcare facilities regularly. Furthermore, receiving treatment at home improves patient comfort and enhances adherence to prescribed therapies.

Cost-Effectiveness and Reduction in Hospital Burden

The growing adoption of home infusion therapy is also supported by its cost-effectiveness compared to inpatient hospital treatment, which often involves substantial expenses related to hospital stays, nursing services, and prolonged patient monitoring. By shifting certain medical treatments from hospitals to home settings, healthcare providers can reduce operational costs and allocate hospital resources more efficiently to patients requiring urgent or critical care. This approach also lowers healthcare expenses for patients and insurance providers. In addition, home infusion therapy minimizes the risk of hospital-acquired infections associated with extended hospital stays. Governments and healthcare organizations are increasingly encouraging the use of home-based healthcare solutions to help manage rising healthcare expenditures. The strong economic advantages associated with home infusion therapy have become a major factor contributing to market growth globally. For example, according to the National Home Infusion Association, the average daily cost of home infusion therapy ranges from US$ 122 to US$ 225, whereas inpatient hospital treatment may cost between US$ 586 and US$ 798 per day depending on the type of care provided.

Technological Advancements in Infusion Devices and Telehealth Support

Ongoing technological advancements in portable infusion devices, intelligent monitoring systems, and telehealth solutions are expected to significantly support the expansion of the home infusion therapy market. Modern infusion pumps are becoming increasingly safe, reliable, and user-friendly, enabling patients and caregivers to manage treatments more effectively at home. Advanced features such as automated alarms, wireless monitoring systems, dose tracking, and remote physician supervision enhance treatment accuracy and patient safety. Telehealth technologies further strengthen home infusion therapy by allowing healthcare professionals to remotely monitor patient progress, adjust treatments, and provide virtual consultations, thereby ensuring continuity of care while reducing the need for frequent hospital or clinic visits. In June 2023, Baxter International introduced its Progressa+ Next Gen ICU bed to better support home-based patient care needs. Technological innovations continue to improve the efficiency of home healthcare services and enable medical professionals to deliver high-quality treatment in home settings more effectively.

Ask Analyst for Customization in Report:https://www.renub.com/request-customization-page.php?gturl=home-infusion-therapy-market-p.php

Country Analysis

United States Home Infusion Therapy Market

The home infusion therapy market in the United States continues to experience strong growth, driven by the aging population, the increasing prevalence of chronic diseases, and rising demand for cost-effective and convenient treatment options. Advancements in infusion technologies, expansion of home healthcare services, and supportive reimbursement policies from Medicare and private insurance providers are further contributing to market development. Strategic acquisitions and product innovations are also strengthening the industry landscape. For example, in April 2023, Memorial Hermann Health System acquired KabaFusion to expand home infusion therapy services in the United States. In addition, in 2024, Baxter International introduced its Novum IQ large-volume infusion pump system capable of connecting with external medical devices. Furthermore, consolidation activities such as the announced US$ 3.60 billion merger between Amedisys and Optum are expected to strengthen market growth. However, challenges including strict regulatory requirements, shortages of skilled healthcare professionals, and supply chain disruptions may limit expansion. Despite these obstacles, the United States remains a dominant player in the global home infusion therapy market due to its strong growth potential and advanced healthcare infrastructure.

Germany Home Infusion Therapy Market

Germany’s home infusion therapy market is witnessing steady growth due to factors such as the rising geriatric population, increasing prevalence of chronic diseases, and growing preference for home-based healthcare services. The country’s well-developed healthcare system and favorable reimbursement policies have improved patient access to outpatient infusion therapies. Technological advancements have also helped address some operational limitations within the market. For instance, in 2024, Fresenius Kabi introduced a new ambulatory infusion device designed to support home-based infusion treatments. Nevertheless, the market still faces certain challenges, including complex regulatory frameworks, shortages of skilled healthcare workers, and logistical constraints related to home healthcare delivery.

India Home Infusion Therapy Market

The home infusion therapy market in India is gradually expanding due to rising healthcare costs, a growing elderly population, and the increasing burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders. With hospitals facing capacity constraints and healthcare systems shifting toward patient-centric treatment approaches, home infusion therapy is increasingly viewed as a convenient and cost-effective alternative for patients. In 2024, Apollo Hospitals expanded its healthcare offerings through the launch of Apollo Home Infusion Services. However, market growth continues to face challenges including limited healthcare infrastructure, shortages of trained medical professionals, regulatory complexities, and insufficient reimbursement support for home-based therapies.

Saudi Arabia Home Infusion Therapy Market

The Saudi Arabia home infusion therapy market is experiencing rapid growth driven by the increasing elderly population, rising incidence of chronic diseases, and growing adoption of home healthcare services. Government investments in healthcare modernization and technological advancements are playing an important role in supporting market expansion. In 2024, Nahdi Medical Company introduced new home healthcare and infusion therapy solutions integrated with digital health technologies for remote patient monitoring. Despite these positive developments, the market faces several constraints, including shortages of qualified healthcare professionals, strict regulatory requirements, and relatively low levels of patient awareness regarding home infusion therapy services. Nevertheless, the Saudi Arabian market continues to present substantial long-term growth opportunities.

Market Segments

Product

·       Infusion Pump

·       Intravenous Sets

·       IV Cannulas

·       Needleless Connectors

Application

·       Anti-Infective

·       Hydration Therapy

·       Chemotherapy

·       Enternal Nutrition

·       Parenteral Nutrition

·       Specialty Pharmaceuticals

·       Others

Country

North America

·       United States

·       Canada

Europe

·       France

·       Germany

·       Italy

·       Spain

·       United Kingdom

·       Belgium

·       Netherlands

·       Turkey

Asia Pacific

·       China

·       Japan

·       India

·       South Korea

·       Thailand

·       Malaysia

·       Indonesia

·       Australia

·       New Zealand

Latin America

·       Brazil

·       Mexico

·       Argentina

Middle East & Africa

·       Saudi Arabia

·       UAE

·       South Africa

All companies have been covered with 5 Viewpoints

·       Overviews

·       Key Person

·       Recent Developments

·       SWOT Analysis

·       Revenue Analysis

Key Players Analysis

·       Pfizer Inc.

·       Smith & Nephew plc

·       Terumo Corporation

·       Johnson & Johnson Services, Inc.

·       Becton, Dickinson and Company

·       Baxter International Inc.

·       ICU Medical

·       Eli Lilly and Company

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.         

Contact Us:

Company Name: Renub Research

Contact Person: Rajat Gupta

Phone No: (D) +91-120-421-9822 (IND)

Website: https://www.renub.com/

Email: rajat@renub.com